XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Basic and Diluted Net (Loss) Income Per Share
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Basic and Diluted Net (Loss) Income Per Share Basic and Diluted Net (Loss) Income Per Share
The following table sets forth the computation of basic and diluted net (loss) income per share attributable to common stockholders, Basic net (loss) income per share is computed by dividing net (loss) income for the period by the weighted-average number of common shares outstanding during the period, which excludes Sponsor Vesting Shares which are legally outstanding, but subject to return to the Company. Diluted net (loss) income per share is computed by dividing net (loss) income for the period by the weighted-average common shares outstanding during the period, plus the dilutive effect of the stock options and RSU awards, as applicable pursuant to the treasury stock method. The following table sets forth the computation of basic and diluted net (loss) income per share:
(In thousands, except for share and per share amounts)Three Months Ended
March 31,
20242023
Numerator:
Net income attributable to common stockholders—Basic$(13,913)$9,769
Net income attributable to common stockholders—Diluted$(13,913)$9,769
Denominator:
Weighted-average common shares outstanding—Basic (1)141,828,895138,651,062
Stock options3,803,307
RSU awards
Weighted-average common shares outstanding—Diluted (1)141,828,895142,454,369
Net income per share—Basic$(0.10)$0.07
Net income per share—Diluted$(0.10)$0.07
(1)Excludes weighted-average Sponsor Vesting Shares subject to return of 4,500,000 shares for the three months ended March 31, 2024 and 2023.
Diluted net (loss) income per share reflects the potential dilution of securities that could share in the earnings of an entity. The following potentially dilutive securities for common stock were outstanding and excluded from diluted net (loss) income per share as they are subject to performance or market conditions that were not achieved as follows:
Three Months Ended
March 31,
20242023
Options to purchase common stock1,481,531 1,481,531 
Performance-based stock awards1,794,893 2,054,650 
Earnout shares25,000,000 25,000,000 
Sponsor vesting shares4,500,000 4,500,000 
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net (loss) income per share attributable to common stockholders for the periods presented because including them would have been antidilutive:
Three Months Ended
March 31,
20242023
Options to purchase common stock3,381,132 — 
Warrants to purchase common stock35,476,627 35,476,627 
RSU awards11,053,204 —